Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy

Journal of Neuroimmunology

Volumn 95, Issue 1-2, 1999, Pages 185-189

  Furuya, Takafumi ^a   Nakamura, Tatsufumi ^a   Fujimoto, Takeshi ^a   Nakane, Shunya ^a   Kambara, Chiaki ^a   Shirabe, Susumu ^a   Hamasaki, Shinji ^a   Motomura, Masakatsu ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

HAM; IFN ; IL 12; Th1; Th2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOLOGICAL TOLERANCE; IMMUNOSURVEILLANCE; MALE; PATHOGENESIS; PRIORITY JOURNAL; SPINAL CORD DISEASE;

ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; TH1 CELLS; TH2 CELLS;

EID: 0033103664     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00263-X     Document Type: Article

References (22)

1. Akizuki S., Nakazato O., Higuchi Y., Tanabe K., Setoguchi M., Yoshida S., Miyazaki Y., Yamamoto S., Sudou S., Sannomiya K., Okajima K. Necropsy findings in HTLV-I-associated myelopathy. Lancet. 1:1987;156-157.
2. + T-cells via CD40 ligand. Proc. Natl. Acad. Sci. U.S.A. 94:1997;599-603.
3. Donckier V., Abramowicz D., Bruyns C., Florquin S., Vaderrhaghen M.-L., Amaraoui Z., Dubois C., Vanernabeele P. IFN-γ prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice. J. Immunol. 153:1994;2361-2368.
4. Germann T., Rude E. Interleukin-12. Int. Arch. Allergy Immunol. 108:1995;103-112.
5. Gessain A., Saal F., Gout O., Daniel M.T., Flandrin G., The G. De., Peries J., Sigaux F. High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood. 75:1990;428-433.
6. Gubler U., Chua A.O., Schoenhaut D.S., Dwyer C.M., McComas W., Motyka R., Nabavi N., Wolitzky A.G., Quinn P.M., Familietti P.C., Gateley M.K. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4143-4147.
7. Itoyama Y., Minato S., Kira J., Goto I., Sato H., Okochi K., Yamamoto N. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I associated myelopathy. Neurology. 38:1988;1302-1307.
8. Itoyama Y., Minato S., Kira J., Goto I., Yamamoto N. Increase in helper inducer T-cells and activated T-cells in HTLV-I-associated myelopathy. Ann. Neurol. 26:1989;257-262.
9. Kuroda Y., Matsui M. Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy. J. Neuroimmunol. 42:1993;223-226.
10. Matsuo H., Nakamura T., Tsujihata M., Kinoshita I., Satoh A., Tomita I., Shirabe S., Shibayama K., Nagataki S. Plasmapheresis in treatment of human T lymphotropic virus type-I-associated myelopathy. Lancet. 2:1988;1109-1113.
11. Mosmann T.R., Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
12. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A., Coffman, R.L., 1986. Two types of murine helper T-cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2357-2384.
13. Nagasato K., Nakamura T., Shirabe S., Shibayama K., Ohishi K., Ichinose K., Tsujihata M., Nagataki S. Presence of serum anti-human T lymphotropic virus type I (HTLV-I) IgM antibodies means persistent active replication of HTLV-I in HTLV-I-associated myelopathy. J. Neurol. Sci. 103:1991;203-208.
14. + cells from patients with HTLV-I-associated myelopathy. Tohoku J. Exp. Med. 179:1996;227-233.
15. Osame, M., 1990. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Blattner, W.A. (Ed.), Human Retrovirology: HTLV. Raven Press, New York, p. 191.
16. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1:1986;1031-1032.
17. Racke M.K., Bnomo A., Scott D.E., Cannella B., Levine A., Raine C.S., Shavach E.M., Rocken M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1994;1961-1966.
18. Sawada M., Suzumura A., Kondo N., Marunouchi T. Induction of cytokines in glial cells by trans-activation of human T-cell lymphotropic virus type I. FEBS Lett. 31:1992;47-50.
19. + T-cells. Annu. Rev. Immunol. 12:1994;635-673.
20. Trembleau S., Penna G., Bosi E., Mortara A., Gately M.K., Adorini L. Interleukin-12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:1995;817-821.
21. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:1995;251-276.
22. Watanabe H., Nakamura T., Nagasato K., Shirabe S., Ohishi K., Ichinose K., Nishiura Y., Chiyoda S., Tsujihata M., Nagataki S. Exaggerated messenger RNA expression of inflammatory cytokines in human T-cell lymphotropic virus type I-associated myelopathy. Arch. Neurol. 52:1995;276-280.